Guerbet Appoints NATIXIS ODDO BHF for Liquidity Contract

Villepinte, 3 February 2025: Guerbet, a global specialist in contrast agents and solutions for medical imaging, has ended its liquidity contract established since March 9, 2022. The company has now engaged NATIXIS and ODDO BHF to initiate a new liquidity contract effective February 3, 2025. This agreement spans a year, with the possibility of tacit renewal.

This contract aligns with the guidelines of the AMF's Decision n°2021-01 and the standard AMAFI contract. The primary goal is to improve the trading conditions of Guerbet's shares on Euronext Paris.

Resources initially allocated include 10,996 shares and €340,083.86. The contract could be suspended under certain conditions, such as Article 5 fulfillment of AMF Decision, or if shares operate outside authorized thresholds. Termination can occur at any time by involved parties.